| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $132.4B | $99.9B | $60.9B | $66.0B | $42.5B | $14.3B | $11.3B | $6.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $4.1B | $3.4B | $2.9B | $2.1B | $1.7B | $0.3B | $0.3B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | $-0.1B | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $6.22 | $8.24 | $11.55 | $10.27 | $5.90 | $4.00 | $1.42 | $0.83 |
| EPS (Diluted) | $5.89 | $7.96 | $11.18 | $10.01 | $5.74 | $3.90 | $1.40 | $0.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.3B | $27.5B | $21.9B | $19.9B | $18.8B | $13.5B | $9.9B | $7.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.6B | $1.3B | $1.1B | $1.1B | $1.1B | $1.0B | $0.5B | $0.3B |
| Total Liabilities | $42.9B | $25.8B | $20.6B | $18.8B | $17.9B | $12.7B | $9.3B | $7.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.4B | $1.7B | $1.4B | $1.1B | $0.9B | $0.8B | $0.6B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $0.5B | $-0.0B | $-0.2B | $2.1B | $2.0B | $0.2B | $-0.1B |
| Investing Cash Flow | $-0.5B | $-0.1B | $-0.1B | $-0.0B | $-0.1B | $-0.2B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.9B | $0.2B | $-0.2B | $0.1B | $-0.0B | $0.3B | $0.0B | $0.1B |